Benin Management Corp’s Acorda Therapeutics ACOR Stock Holding History

Benin Management Corp’s Portfolio ACOR Stock Details ACOR Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q1	–	Sell	-106	Closed	-$9K	–	102
2020 Q4	$9K	Buy	106 +8	+8%	+$736	﹤0.01%	95
2020 Q3	$6K	Hold	98	–	–	﹤0.01%	89
2020 Q2	$9K	Hold	98	–	–	﹤0.01%	86
2020 Q1	$11K	Hold	98	–	–	0.01%	84
2019 Q4	$24K	Hold	98	–	–	0.01%	91
2019 Q3	$34K	Hold	98	–	–	0.01%	92
2019 Q2	$90K	Hold	98	–	–	0.04%	93
2019 Q1	$156K	Hold	98	–	–	0.07%	92
2018 Q4	$183K	Hold	98	–	–	0.09%	89
2018 Q3	$230K	Hold	98	–	–	0.09%	91
2018 Q2	$336K	Hold	98	–	–	0.15%	77
2018 Q1	$277K	Buy	+98	New	+$293K	0.12%	85

Other funds holding ACOR

Point72 Asset Management Stamford, Connecticut $78.1B AUM 55.25% 1-Year Est. Return

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

Acadian Asset Management Boston, Massachusetts $70.5B AUM 36% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Jacobs Levy Equity Management Florham Park, New Jersey $23.8B AUM 25.4% 1-Year Est. Return

CCA

Canyon Capital Advisors Dallas, Texas $772M AUM 32.81% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Federated Hermes Pittsburgh, Pennsylvania $61.5B AUM 30.7% 1-Year Est. Return

Susquehanna International Group Bala Cynwyd, Pennsylvania $893B AUM 36.07% 1-Year Est. Return

Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

Benin Management Corp's ACOR Position: Q1 2021 in Review

Benin Management Corp sold out of Acorda Therapeutics (ACOR) in Q1 2021, closing a stake of 106 shares — an estimated $9K sold.

Benin Management Corp first reported a position in ACOR in Q1 2018 and held it in 12 quarters. The position peaked at $336K in Q2 2018. 32 funds tracked by Wall St. Rank hold ACOR as of Q1 2021.

Benin Management Corp reported no remaining Acorda Therapeutics position as of Q1 2021 after selling out during the quarter.
Benin Management Corp sold 106 Acorda Therapeutics shares in Q1 2021, an estimated $9K.
Benin Management Corp first reported a position in Acorda Therapeutics in Q1 2018 and held it in 12 quarters.
Benin Management Corp's Acorda Therapeutics position peaked at $336K in Q2 2018.
32 funds tracked by Wall St. Rank held Acorda Therapeutics as of Q1 2021.

Based on Benin Management Corp's 13F filing for Q1 2021, filed 27 Apr 2021.